Healthcare -
Biotechnology - NASDAQ - US
$ 5.71
-3.06 %
$ 41.7 M
Market Cap
-0.44
P/E
KZR - STOCK-BASED COMPENSATION
Stock-based Compensation KZR - Kezar Life Sciences, Inc.
18.1 M
LAST VALUE
54.52%
2 YEAR CAGR
55.53%
5 YEAR CAGR
0.00%
10 YEAR CAGR